Stocks News

LAST PRICE
141.2650
TODAY'S CHANGE (%)
Trending Down-1.0250 (-0.7204%)

Bid / Lots
141.1400/ 2
Ask / Lots
141.3500/ 2
Open / Previous Close
142.3000 / 142.2900
Day Range
Low 139.7700
High 143.0500
52 Week Range
Low 89.0400
High 148.3699
Volume
196,879
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 16, 2024
- Neurocrine Biosciences Insider Sold Shares Worth $4,138,436, According to a Recent SEC Filing, from 4:47PM ET on Thursday May 16, 2024 by MT Newswires
  4:47PM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: NBIX
  04:47 PM EDT, 05/16/2024 (MT Newswires) -- Matt Abernethy, Chief Financial Officer, on May 14, 2024, sold 30,000 shares in Neurocrine Biosciences (NBIX) for $4,138,436. Following the Form 4 filing with the SEC, Abernethy has control over a total of ...
May 15, 2024
- DJ S&P 500 Futures Steady In Premarket Trading; Monday.Com, Nextracker Lead, from 7:31AM ET on Wednesday May 15, 2024 by Dow Jones
  7:31AM ET on Wednesday May 15, 2024 by Dow Jones
  Companies Mentioned: NBIX, MEDP, ALNY, FOUR, MNDY, NU, NXT
  
  This article was automatically generated by Barrons.com using technology from Automated Insights.
  
  With U.S. stock markets set to open in two hours, monday.com Ltd. (MNDY) was up 19.4% in pre-market trading, and Nextracker Inc. (NXT) was up 13.9%.
May 14, 2024
- Neurocrine Biosciences Presented Baseline Data from the CAHtalyst™ Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024, from 8:30AM ET on Tuesday May 14, 2024 by PR Newswire
  8:30AM ET on Tuesday May 14, 2024 by PR Newswire
  Companies Mentioned: NBIX
  CAHtalyst™ Phase 3 Baseline Characteristics Highlight Limitations of Current CAH Treatment Paradigm in Children, Adolescents and Adults- Phase 2 Study for Modified-Release Hydrocortisone in Adults with Adrenal Insufficiency Demonstrated Participants Achieved Physiological MorningCortisol Levels after 4 Weeks- Phase 3 Extension Study Data for Modified-Release Hydrocortisone in Adults with CAH Demonstrated Reduction in Median Daily Hydrocortisone Dose and an Increase in Responders at Levels ≤ 25 mg/day
- Neurocrine Biosciences Presented Baseline Data from the CAHtalyst(TM) Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024, from 8:30AM ET on Tuesday May 14, 2024 by Dow Jones
  8:30AM ET on Tuesday May 14, 2024 by Dow Jones
  Companies Mentioned: NBIX
  
  Neurocrine Biosciences Presented Baseline Data from the CAHtalyst(TM) Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024
- DJ Neurocrine Initiated at Outperform by Evercore ISI Group, from 5:26AM ET on Tuesday May 14, 2024 by Dow Jones
  5:26AM ET on Tuesday May 14, 2024 by Dow Jones
  Companies Mentioned: NBIX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/NBIX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 14, 2024 05:26 ET (09:26 GMT)

May 17, 2024
- Medpace Holdings Insider Sold Shares Worth $15,924,222, According to a Recent SEC Filing, from 4:17PM ET on Friday May 17, 2024 by MT Newswires
  4:17PM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: MEDP
- --Baird Downgrades BioMarin Pharmaceutical to Neutral From Outperform, Cuts Price Target to $72 From $104, from 7:29AM ET on Friday May 17, 2024 by MT Newswires
  7:29AM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: BMRN
May 16, 2024
- United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing, from 4:41PM ET on Thursday May 16, 2024 by MT Newswires
  4:41PM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: UTHR
May 14, 2024
- United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing, from 4:39PM ET on Tuesday May 14, 2024 by MT Newswires
  4:39PM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: UTHR
- Medpace Holdings Insider Sold Shares Worth $1,996,723, According to a Recent SEC Filing, from 4:25PM ET on Tuesday May 14, 2024 by MT Newswires
  4:25PM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: MEDP
May 13, 2024
- Biomarin Pharmaceutical Insider Sold Shares Worth $3,255,200, According to a Recent SEC Filing, from 4:14PM ET on Monday May 13, 2024 by MT Newswires
  4:14PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: BMRN
- Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test, from 4:18AM ET on Monday May 13, 2024 by MT Newswires
  4:18AM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: QGEN
May 10, 2024
- United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing, from 4:41PM ET on Friday May 10, 2024 by MT Newswires
  4:41PM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: UTHR
May 8, 2024
- United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing, from 5:15PM ET on Wednesday May 08, 2024 by MT Newswires
  5:15PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: UTHR
- Medpace Holdings Insider Sold Shares Worth $21,129,347, According to a Recent SEC Filing, from 4:54PM ET on Wednesday May 08, 2024 by MT Newswires
  4:54PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: MEDP

Neurocrine Biosciences Inc
NASDAQ:NBIXUnited States

Search Criteria

May 16, 2024

Neurocrine Biosciences Insider Sold Shares Worth $4,138,436, According to a Recent SEC Filing, from 4:47PM ET on Thursday May 16, 2024 by MT Newswires

May 15, 2024

DJ S&P 500 Futures Steady In Premarket Trading; Monday.Com, Nextracker Lead, from 7:31AM ET on Wednesday May 15, 2024 by Dow Jones

May 14, 2024

Neurocrine Biosciences Presented Baseline Data from the CAHtalyst™ Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024, from 8:30AM ET on Tuesday May 14, 2024 by PR Newswire

Neurocrine Biosciences Presented Baseline Data from the CAHtalyst(TM) Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024, from 8:30AM ET on Tuesday May 14, 2024 by Dow Jones

DJ Neurocrine Initiated at Outperform by Evercore ISI Group, from 5:26AM ET on Tuesday May 14, 2024 by Dow Jones

Peers Headlines

May 17, 2024

Medpace Holdings Insider Sold Shares Worth $15,924,222, According to a Recent SEC Filing, from 4:17PM ET on Friday May 17, 2024 by MT Newswires

--Baird Downgrades BioMarin Pharmaceutical to Neutral From Outperform, Cuts Price Target to $72 From $104, from 7:29AM ET on Friday May 17, 2024 by MT Newswires

May 16, 2024

United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing, from 4:41PM ET on Thursday May 16, 2024 by MT Newswires

May 14, 2024

United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing, from 4:39PM ET on Tuesday May 14, 2024 by MT Newswires

Medpace Holdings Insider Sold Shares Worth $1,996,723, According to a Recent SEC Filing, from 4:25PM ET on Tuesday May 14, 2024 by MT Newswires

May 13, 2024

Biomarin Pharmaceutical Insider Sold Shares Worth $3,255,200, According to a Recent SEC Filing, from 4:14PM ET on Monday May 13, 2024 by MT Newswires

Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test, from 4:18AM ET on Monday May 13, 2024 by MT Newswires

May 10, 2024

United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing, from 4:41PM ET on Friday May 10, 2024 by MT Newswires

May 8, 2024

United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing, from 5:15PM ET on Wednesday May 08, 2024 by MT Newswires

Medpace Holdings Insider Sold Shares Worth $21,129,347, According to a Recent SEC Filing, from 4:54PM ET on Wednesday May 08, 2024 by MT Newswires